Delivery Order SPE2DB24D1034-SPE2DB25FWFH7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,739.88 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Progesterone 200 mg capsules (100-count units) with a ceiling value of $1,262.52. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract's place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $11,088.40. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,358.57 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $1,001.26 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a contract value of $1,503.95. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $10,032.28 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,217.40 and an ultimate completion date of September 15, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child delivery order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFH7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $14,395.56. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant role in federal medical procurement for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for progesterone represents a routine pharmaceutical supply transaction under the DLA's comprehensive global pharmaceutical support vehicle, which enables flexible fulfillment of military healthcare requirements worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 8/27/25 |